Financials

v3.7.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2016
Dec. 31, 2015
Current assets:    
Cash $ 594 $ 8,811
Prepaid expenses 44,854 1,825
Other intangible assets 12,778 0
Due from related party 0 5,000
Total current assets 58,226 15,636
Property and equipment, net 6,131 7,247
Other assets:    
Patents, net 1,379,943 0
Goodwill 166,000 0
Deposits-other 2,315 0
Total other assets 1,548,258 0
Total Assets 1,612,615 22,883
Current liabilities:    
Notes and debentures payable 114,259 0
Accounts payable and accrued expenses 351,143 24,516
Accrued interest payable - related party 71,309 3,048
Accrued interest payable 17,615 0
Total current liabilities 554,326 27,564
Long term debt:    
Notes payable - related party 1,054,325 130,572
Total Liabilities 1,608,651 158,136
Stockholders' equity (deficiency):    
Common stock $0.0002 par value, 1,500,000,000 shares authorized; 1,481,754,533 and -0- shares issued and outstanding at December 31, 2016 and December 31, 2015, respectively 296,351 0
Additional paid-in capital 586,336 (952)
Accumulated deficit (880,104) (135,253)
Total Stockholders' Equity (Deficiency) 3,964 (135,253)
Total Liabilities and Stockholders' Equity (Deficiency) 1,612,615 22,883
Series A Preferred Stock [Member]    
Stockholders' equity (deficiency):    
Preferred Stock Value 69 0
Total Stockholders' Equity (Deficiency) 69 0
Series B Preferred Stock [Member]    
Stockholders' equity (deficiency):    
Preferred Stock Value 1,312 952
Total Stockholders' Equity (Deficiency) $ 1,312 $ 952
v3.7.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
7 Months Ended 12 Months Ended
Dec. 31, 2015
Dec. 31, 2016
Income:    
Revenue $ 0 $ 0
Expenses:    
Research and development 4,798 300,985
General and administrative 118,655 383,784
Interest 11,800 60,082
Total expenses 135,253 744,851
Net loss $ (135,253) $ (744,851)
Loss per share:    
Basic and diluted (in dollars per share)   $ (0.002)
Weighted average shares outstanding, basic and diluted (in shares)   372,462,888
v3.7.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
7 Months Ended 12 Months Ended
Dec. 31, 2015
Dec. 31, 2016
Cash Flows from Operating Activities    
Net loss $ (135,253) $ (744,851)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 558 1,116
Amortization 0 27,279
Change in:    
Prepaid expenses (1,825) 3,484
Accounts payable and accrued liabilities 27,564 140,172
Net cash used in operating activities (108,956) (572,800)
Cash Flows from Investing Activities    
Cash acquired in reverse acquisition 0 75,687
Purchase of property and equipment (7,805) 0
Net payments from (advances to) related party (5,000) 5,000
Purchase of intangible assets 0 (20,000)
Net cash provided by (used in) investing activities (12,805) 60,687
Cash Flows from Financing Activities    
Payments on insurance premium financing 0 (15,364)
Proceeds from notes payable-related party 130,572 519,260
Net cash provided by financing activities 130,572 503,896
Net change in cash 8,811 (8,217)
Cash, beginning of period 0 8,811
Cash, end of period 8,811 594
Supplement Disclosure of Cash flow Information    
Cash paid during the year for interest 8,752 290
Non-cash investing activities    
Share exchange transaction $ 0 $ 884,068